• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中枢神经系统药物研发中的专利体外血脑屏障模型。

Patented in vitro blood-brain barrier models in CNS drug discovery.

作者信息

Tóth Andrea, Veszelka Szilvia, Nakagawa Shinsuke, Niwa Masami, Deli Mária A

机构信息

Laboratory of Molecular Neurobiology, Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, Szeged, Hungary.

出版信息

Recent Pat CNS Drug Discov. 2011 May 1;6(2):107-18. doi: 10.2174/157488911795933910.

DOI:10.2174/157488911795933910
PMID:21585327
Abstract

The blood-brain barrier (BBB) is a regulatory interface between the circulation and the central nervous system (CNS). Therapy of neurological diseases is limited due to restricted penetration of pharmacons across the BBB. Models for screening the brain penetration of drug candidates are needed early in drug discovery. Culture-based models are useful tools for both basic research on BBB, and testing the permeability of new therapeutical molecules. This review focuses on patented in vitro BBB models and their potential application in CNS drug discovery. Cell culture models using primary and immortalized brain endothelial cells of non-human and human origin, in co-culture or mono-culture setting, in static or dynamic conditions are discussed, as well as methods to induce BBB properties in such in vitro models. The aim of these models is to reproduce as many aspects as possible of the in vivo BBB. All models should show some elements of general endothelial and specific BBB properties, like physiologically realistic cell architecture, restrictive paracellular pathway, and functional expression of transport mechanisms. Though no "ideal in vitro BBB model" has been constructed yet, the currently available models provide valuable information on BBB permeability and are useful tools in CNS drug discovery.

摘要

血脑屏障(BBB)是循环系统与中枢神经系统(CNS)之间的调节界面。由于药物通过血脑屏障的渗透性受限,神经系统疾病的治疗受到限制。在药物研发早期就需要用于筛选候选药物脑渗透性的模型。基于细胞培养的模型对于血脑屏障的基础研究以及测试新治疗分子的渗透性都是有用的工具。本综述聚焦于已获专利的体外血脑屏障模型及其在中枢神经系统药物研发中的潜在应用。讨论了使用源自非人类和人类的原代及永生化脑内皮细胞的细胞培养模型,这些模型采用共培养或单培养方式,处于静态或动态条件下,还讨论了在这类体外模型中诱导血脑屏障特性的方法。这些模型的目的是尽可能多地重现体内血脑屏障的各个方面。所有模型都应展现出一些一般内皮细胞特性和特定血脑屏障特性的要素,比如生理上逼真的细胞结构、限制性细胞旁途径以及转运机制的功能性表达。尽管尚未构建出“理想的体外血脑屏障模型”,但目前可用的模型提供了有关血脑屏障渗透性的有价值信息,并且是中枢神经系统药物研发中的有用工具。

相似文献

1
Patented in vitro blood-brain barrier models in CNS drug discovery.中枢神经系统药物研发中的专利体外血脑屏障模型。
Recent Pat CNS Drug Discov. 2011 May 1;6(2):107-18. doi: 10.2174/157488911795933910.
2
New experimental models of the blood-brain barrier for CNS drug discovery.用于中枢神经系统药物发现的血脑屏障新实验模型。
Expert Opin Drug Discov. 2017 Jan;12(1):89-103. doi: 10.1080/17460441.2017.1253676. Epub 2016 Nov 7.
3
Human iPSC-Derived Blood-Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development?人诱导多能干细胞衍生的血脑屏障模型:在临床前药物发现和开发方面的有价值工具?
Curr Protoc Stem Cell Biol. 2020 Dec;55(1):e122. doi: 10.1002/cpsc.122.
4
Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.体外血脑屏障模型在治疗亨廷顿病的实验性候选药物选择中的应用。
Mol Pharm. 2019 May 6;16(5):2069-2082. doi: 10.1021/acs.molpharmaceut.9b00042. Epub 2019 Apr 4.
5
Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.血脑屏障模型:中枢神经系统靶向生物治疗药物临床前开发中从体外到体内的转化
Expert Opin Drug Discov. 2015 Feb;10(2):141-55. doi: 10.1517/17460441.2015.974545. Epub 2014 Nov 12.
6
Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier.使用体外细胞培养作为血脑屏障通透性筛选的进展与局限
J Pharm Sci. 2001 Nov;90(11):1681-98. doi: 10.1002/jps.1119.
7
Progress in brain penetration evaluation in drug discovery and development.药物研发中脑渗透评估的进展
J Pharmacol Exp Ther. 2008 May;325(2):349-56. doi: 10.1124/jpet.107.130294. Epub 2008 Jan 18.
8
An Improved In Vitro Porcine Blood-Brain Barrier Model for Permeability Screening and Functional Studies.用于通透性筛选和功能研究的改良体外猪血脑屏障模型。
Methods Mol Biol. 2022;2492:131-142. doi: 10.1007/978-1-0716-2289-6_7.
9
Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.载体介导的转运系统对血脑屏障作为大脑支持和保护界面的作用;对中枢神经系统药物发现与开发的重要性。
Pharm Res. 2007 Sep;24(9):1745-58. doi: 10.1007/s11095-007-9374-5. Epub 2007 Jul 10.
10
New Blood-Brain Barrier Models Using Primary Parkinson's Disease Rat Brain Endothelial Cells and Astrocytes for the Development of Central Nervous System Drug Delivery Systems.利用原发性帕金森病大鼠脑内皮细胞和星形胶质细胞建立新的血脑屏障模型用于中枢神经系统药物递送系统的开发
ACS Chem Neurosci. 2021 Oct 20;12(20):3829-3837. doi: 10.1021/acschemneuro.1c00118. Epub 2021 Oct 8.

引用本文的文献

1
Regulation of BBB function and pathological evolution of PD by microenvironment "spatiotemporal gradient": unique advantages of microfluidic chips.微环境“时空梯度”对血脑屏障功能的调控及帕金森病的病理演变:微流控芯片的独特优势
Front Aging Neurosci. 2025 Jul 9;17:1599509. doi: 10.3389/fnagi.2025.1599509. eCollection 2025.
2
Experimental Models to Study the Functions of the Blood-Brain Barrier.用于研究血脑屏障功能的实验模型
Bioengineering (Basel). 2023 Apr 25;10(5):519. doi: 10.3390/bioengineering10050519.
3
Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review.
基于脑靶向的载白藜芦醇纳米载体在阿尔茨海默病中的研究进展。
IET Nanobiotechnol. 2023 May;17(3):154-170. doi: 10.1049/nbt2.12127. Epub 2023 Mar 22.
4
Models of the Blood-Brain Barrier: Tools in Translational Medicine.血脑屏障模型:转化医学中的工具
Front Med Technol. 2021 Feb 15;2:623950. doi: 10.3389/fmedt.2020.623950. eCollection 2020.
5
Characterization of a Primate Blood-Brain Barrier Co-Culture Model Prepared from Primary Brain Endothelial Cells, Pericytes and Astrocytes.由原代脑内皮细胞、周细胞和星形胶质细胞制备的灵长类动物血脑屏障共培养模型的表征
Pharmaceutics. 2021 Sep 16;13(9):1484. doi: 10.3390/pharmaceutics13091484.
6
The endo-lysosomal system of bEnd.3 and hCMEC/D3 brain endothelial cells.脑内皮细胞 bEnd.3 和 hCMEC/D3 的内溶酶体系统。
Fluids Barriers CNS. 2019 May 30;16(1):14. doi: 10.1186/s12987-019-0134-9.
7
Analysis of the trafficking system in blood-brain barrier models by high content screening microscopy.通过高内涵筛选显微镜分析血脑屏障模型中的转运系统。
Neural Regen Res. 2018 Nov;13(11):1883-1884. doi: 10.4103/1673-5374.239435.
8
Acute intermittent hypoxia and rehabilitative training following cervical spinal injury alters neuronal hypoxia- and plasticity-associated protein expression.急性间歇性低氧及颈髓损伤后康复训练改变神经元低氧和可塑性相关蛋白的表达。
PLoS One. 2018 May 18;13(5):e0197486. doi: 10.1371/journal.pone.0197486. eCollection 2018.
9
Comprehensive evaluation of blood-brain barrier-forming micro-vasculatures: Reference and marker genes with cellular composition.血脑屏障形成微血管的综合评估:具有细胞组成的参考和标记基因。
PLoS One. 2018 May 15;13(5):e0197379. doi: 10.1371/journal.pone.0197379. eCollection 2018.
10
Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.研究性化疗和新型药代动力学机制治疗乳腺癌脑转移。
Pharmacol Res. 2018 Jun;132:47-68. doi: 10.1016/j.phrs.2018.03.021. Epub 2018 Mar 28.